Publication | Open Access

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study

Bipolar Androgen TherapyUrologyOncologyMulticohort StudyMedicineBenign Prostatic HyperplasiaPharmacotherapyProstatic DiseasePhase 2Pharmacology